Research programme: histone deacetylase inhibitors - S*BIO/Karolinska InstituteAlternative Names: HDAC inhibitors - S*BIO/Karolinska Institute
Latest Information Update: 12 Aug 2010
At a glance
- Originator Karolinska Institute; S*BIO
- Class Small molecules
- Mechanism of Action Histone deacetylase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 15 Jan 2007 Preclinical trials in Cancer in Sweden (PO)
- 15 Jan 2007 Preclinical trials in Cancer in Singapore (PO)